title: How do we define complete remission for acute myeloid leukemia in the current era? Results of an international survey.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Burke
authors.forename: Linda
authors.initials: L
authors.lastname: Burns
authors.forename: Michael A
authors.initials: MA
authors.lastname: Linden
authors.forename: Bruce
authors.initials: B
authors.lastname: Lindgren
authors.forename: Michael R
authors.initials: MR
authors.lastname: Verneris
authors.forename: Daniel
authors.initials: D
authors.lastname: Weisdorf
authors.forename: Celalettin
authors.initials: C
authors.lastname: Ustun
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D006305:Health Status Indicators; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D012074:Remission Induction; D009626:Terminology as Topic
chemical_list: D000970:Antineoplastic Agents